Inventor · disambiguated record
Xiaojiang Cui
Also filed as: CUI XIAOJIANG
5 granted patents·9 pending applications·13 citations·filing 2010–2020
72Inventor score
Top patents by PatentIndex Score
14 records- 0185US9850293B2Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticleCEDARS SINAI MEDICAL CENTER·Filed 2015·Granted Dec 26, 2017·9 cites·14 claims
- 0275US10738323B2Generation of induced pluripotent stem cells from normal human mammary epithelial cellsCEDARS SINAI MEDICAL CENTER·Filed 2014·Granted Aug 11, 2020·3 cites·15 claims
- 0365US9074253B2Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer typesWAYNE JOHN CANCER INST·Filed 2013·Granted Jul 7, 2015·1 cites·2 claims
- 0460US2015071852A1Foxc1 antibodies and methods of their useWAYNE JOHN CANCER INST·Filed 2014·Application pending·0 cites
- 0559US2020332316A1Generation of induced pluripotent stem cells from normal human mammary epithelial cellsCEDARS SINAI MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 0657US2020025764A1Foxc1 antibodies and methods of their useWAYNE JOHN CANCER INST·Filed 2019·Application pending·0 cites
- 0755US2017108500A1Foxc1 antibodies and methods of their useWAYNE JOHN CANCER INST·Filed 2016·Application pending·0 cites
- 0854US2020325544A1Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer typesWAYNE JOHN CANCER INST·Filed 2020·Application pending·0 cites
- 0951US2012201752A1Foxc1 antibodies and methods of their useCUI XIAOJIANG·Filed 2012·Application pending·0 cites
- 1044US2018066033A1Targeting trastuzumab-resistant her2+ breast cancer with a her3-targeting nanoparticleCEDARS SINAI MEDICAL CENTER·Filed 2017·Application pending·0 cites
- 1141US2015376712A1Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer typesWAYNE JOHN CANCER INST·Filed 2015·Application pending·0 cites
- 1240US11913022B2In vitro induction of mammary-like differentiation from human pluripotent stem cellsCEDARS SINAI MEDICAL CENTER·Filed 2018·Granted Feb 27, 2024·0 cites·19 claims
- 1340US2011150979A1Methods for diagnosis, prognosis and treatment of primary and metastatic basal-like breast cancer and other cancer typesRAY PARTHA S·Filed 2010·Application pending·0 cites
- 1433US10253368B2Molecular signatures of ovarian cancerCEDARS SINAI MEDICAL CENTER·Filed 2015·Granted Apr 9, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Xiaojiang Cui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →